Actively Recruiting
Treatment Outcomes of Esophageal Cancer
Led by University of California, San Francisco · Updated on 2024-09-19
2476
Participants Needed
6
Research Sites
330 weeks
Total Duration
On this page
Sponsors
U
University of California, San Francisco
Lead Sponsor
W
Westat
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will be a carried out through a prospective observational cohort design in conjunction with researchers in the African Esophageal Cancer Consortium (AfrECC). The purpose of this research is to prospectively evaluate outcomes related to existing treatment strategies for esophageal cancer (EC) at participating sites within AfrECC.
CONDITIONS
Official Title
Treatment Outcomes of Esophageal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants with histopathologically confirmed or presumptive clinical diagnosis of esophageal cancer
- Age 18 years of age or older
You will not qualify if you...
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Tenwek Hospital
Bomet, Kenya
Actively Recruiting
2
Moi Teaching and Referral Hospital
Eldoret, Kenya
Actively Recruiting
3
Kamuzu Central Hospital
Lilongwe, Malawi
Actively Recruiting
4
Muhimbili National Hospital
Dar es Salaam, Tanzania
Actively Recruiting
5
Ocean Road Cancer Institute
Dar es Salaam, Tanzania
Actively Recruiting
6
Kilimanjaro Christian Medical Centre
Moshi, Tanzania
Actively Recruiting
Research Team
G
Geoffrey Buckle, MD, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here